Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary Cancers
- Status
- TERMINATED
- Phase
- PHASE2
P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pembrolizumab Plus Y90 Radioembolization in HCC Subjects
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062)
- Status
- TERMINATED
- Phase
- PHASE1
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine and Pembrolizumab in Treating Patients With Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2
Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC
- Status
- COMPLETED
- Phase
- PHASE2
Dendritic Cell Vaccination in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab in Patients With Leptomeningeal Disease
- Status
- TERMINATED
- Phase
- PHASE2